Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Cross-Sectional Study
75%
Malignant Neoplasm
55%
Nanoparticle
47%
Pharmacokinetic
43%
Prevalence
43%
Bioavailability
41%
Nanoemulsion
40%
Antiinfective Agent
32%
Diabetes Mellitus
30%
Infection
29%
Antioxidant
27%
Tablet
25%
Pharmacy Practice
25%
Cytotoxicity
23%
Cross Sectional Study
22%
Chitosan
22%
Brain Ischemia
22%
Alzheimer's Disease
22%
Community Pharmacy
22%
Drug Delivery System
21%
Ultra High Performance Liquid Chromatography
21%
Breast Cancer
21%
Adverse Drug Reaction
21%
IC50
20%
Wound Healing
20%
Biological Activity
20%
Phytochemical
20%
Blood-Brain Barrier
18%
Thymoquinone
18%
Anti-Inflammatory Drug
18%
Drug Release
18%
Congestive Heart Failure
18%
Curcumin
17%
Natural Product
17%
Global Disease Burden
17%
Inflammation
17%
Maturity Onset Diabetes of the Young
17%
Antibiotics
17%
Coronavirinae
16%
Side Effect
16%
SARS Coronavirus
15%
Clinical Trial
15%
Antioxidant Capacity
14%
Self-Medication
13%
Flavonoid
13%
Calcium Ion
13%
Combination Therapy
13%
Nanocarrier
13%
Luteolin
12%
Methylglyoxal
12%
Biological Marker
12%
microRNA
12%
Monkeypox
12%
Polypharmacy
12%
Quercetin
12%
Neurologic Disease
12%
HIV
11%
Cyclodextrin
11%
Chitosan Nanoparticle
11%
Cardiovascular Disease
11%
Cytokine
11%
Direct Oral Anticoagulant
11%
Clinical Pharmacy
11%
Immunosuppressive Agent
10%
Drug Interaction
10%
Parkinson's Disease
10%
Zeta Potential
10%
Dosage Form
10%
Apigenin
10%
Carboxamide
9%
Lung Cancer
9%
Carbon Nanotube
9%
Novel Drug Delivery System
9%
Poloxamer
9%
Repurposing
9%
Targeted Drug Delivery
9%
Randomized Controlled Trial
9%
Pharmacovigilance
9%
Absorption-Distribution-Metabolism-Excretion Toxicity
9%
Hyperglycemia
9%
Solid Lipid Nanoparticle
9%
Drug Repositioning
9%
Chronic Disease
8%
Colistimethate
8%
Silver Nanoparticle
8%
Comorbidity
8%
Rutin
8%
Pseudomonas aeruginosa
8%
Hospital Pharmacy
8%
Anticonvulsive Agent
8%
Nanomaterial
8%
Syndrome
8%
Microorganism
8%
Monkeypox Virus
8%
Catechin
8%
Pharmacodynamics
8%
Human Immunodeficiency Virus 1 Infection
8%
Helicobacter pylori
8%
Antibiotic Resistance
8%
Medicine and Dentistry
COVID-19
29%
Diseases
24%
Cross Sectional Study
19%
Diabetes Mellitus
19%
Diabetes
16%
Infection
16%
Prevalence
15%
Awareness
14%
Cardiovascular Disease
13%
Global Disease Burden
12%
Methylglyoxal
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Medication Compliance
10%
Medicine
9%
Congestive Heart Failure
9%
Maturity Onset Diabetes of the Young
9%
Community Pharmacy
9%
Systematic Review
9%
Biological Marker
8%
Human immunodeficiency virus
8%
Coronavirinae
7%
Anemia
7%
Gut Microbiota
7%
Retrospective Study
7%
Meta-Analysis
7%
Homeopathy
7%
Nephrotoxicity
7%
Direct Oral Anticoagulant
7%
Thromboprophylaxis
7%
Complementary and Alternative Medicine
7%
Patient with Type 2 Diabetes
7%
Prostate Cancer
7%
Natural Product
6%
Life Expectancy
6%
Health Outcomes
6%
Health Care Personnel
6%
Malignant Neoplasm
6%
Insulin Dependent Diabetes Mellitus
6%
Disability Adjusted Life Years
6%
Kidney Graft
6%
Alzheimer's Disease
5%
Antineoplastic Activity
5%
Counseling
5%
Probiotics
5%
Hospital Pharmacy
5%
Intensive Care Unit
5%